INS and diabetes mellitus: The past 2 decades have seen sustained progress in the generation of insulin producing islet-like structures, derived from embryonic (ESC) or induced pluripotent (iPSC) stem-cells, exhibiting a fully mature β-cell phenotype and able to reverse diabetes in a variety of animal models [1–7].